Injectable platelet rich fibrin: cell content, morphological, and protein characterization
Original Article
First Online: 12 July 2018
Abstract
Objectives
The
aim of the present study was to evaluate the blood cell content,
morphological aspects, gene expression of type I collagen, and release
of growth factors on an injectable platelet rich fibrin (i-PRF).
Materials and methods
Blood
samples were collected from 15 volunteers to prepare i-PRF samples.
Peripheral blood was used as a control group. Blood clot and i-PRF
samples were cultured for 10 days. The supernatant of the samples was
collected for ELISA immunoassay quantification of PDGF and VEGF growth
factors over periods of 1, 8, 24, 72, and 240 h. I-PRF and blood clot
samples were biologically characterized using histological and
immunohistochemistry analysis for IL-10, osteocalcin, and TGF-β.
Scanning electron microscopy (SEM) was used to inspect the fibrin
network and distribution of blood platelets and leukocytes. Reverse
transcriptase polymerase chain reaction (RT-PCR) method was used to
evaluate gene expression for type I collagen.
Results
A higher concentration of platelets and lymphocytes was recorded in i-PRF than in peripheral blood (p < 0.05). The release of VEGF was higher in blood clot samples (1933 ± 704) than that for i-PRF (852 ± 376; p < 0.001).
Immunohistochemistry showed upregulation of TGF-B, IL-10, and
osteocalcin in the i-PRF group. RT-PCR showed increased type I collagen
gene expression in i-PRF (p < 0.05).
SEM images revealed agglomeration of platelets in some regions, while a
fibrin networking was noticeable in the entire i-PRF sample.
Conclusions
Injectable
platelet rich fibrin becomes a good approach for soft and mineralized
tissue healing considering the formation of a three-dimensional fibrin
network embedding platelets, leukocytes, type I collagen, osteocalcin,
and growth factors. Indeed, the injectable platelet rich fibrin can be
indicated in several medical applications regarding bioactivity,
simplied technique, and flowable mixing with other biomaterials.
Clinical relevance
Morphological,
cell, and protein characterization of platelet rich fibrin provides a
better understanding of the clinical effects and improvement of clinical
guidelines for several medical applications. Once well physicochemical
and biologically characterized, the use of an injectable platelet rich
fibrin can be extended to other applications in the field of
orthopedics, periodontics, and implant dentistry on the repairing
process of both soft and mineralized tissues.
Comments